Status:
COMPLETED
Assessing the Impact of Brief CBTi on Dissociative Seizures: SCED
Lead Sponsor:
University of Glasgow
Collaborating Sponsors:
William Quarriers Scottish Epilepsy Centre
Conditions:
Dissociative Seizures
Functional Seizures
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Some people experience a temporary change in behaviour and consciousness, that often involves a collapse and/or shaking limb movements. These are referred to as 'Dissociative seizures'. Those who expe...
Detailed Description
Design: This study will use a Multiple Baseline Single Case Experimental Design (SCED). This design has been chosen as it can test the effectiveness of an intervention on a small number of participant...
Eligibility Criteria
Inclusion
- aged 18+ (no upper age limit);
- can speak and read English fluently;
- must score ≤16 on the Sleep Conditions Indicator (SCI);
- must demonstrate compelling evidence that at least some of their seizures are likely to be dissociative, based on at least one of the following:
- 1\) Opinion of the referring consultant, WQSEC consultant, or WQSEC clinical nurse specialist, based on:
- Direct witnessing of seizure(s)
- Review of video footage
- Semiology as suggested by reliable patient or family history. 2)EEG assessment showing seizures without EEG change correlated. The participant must have received feedback that they are experiencing dissociative seizures and is accepting of this as an explanation.
Exclusion
- active and significant mental health problems and/or moderate to severe learning disabilities (IQ score of ≤50);
- unable to give informed consent;
- non-fluent English speakers;
- current participation in another research study;
- dissociative seizures that have been assessed by the WQSEC clinical psychologist and/or consultant as potentially deliberate behaviour driven by secondary gain.
Key Trial Info
Start Date :
May 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 29 2025
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT06145971
Start Date
May 6 2024
End Date
March 29 2025
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
William Quarrier Scottish Epilepsy Centre
Glasgow, United Kingdom, G51 4QD